Li et al.’s 2021 Meta-Analysis: Insights on Neuromodulation for TRD
Introduction: Li et al. (2021), in their meta-analysis published in Journal of Affective Disorders, assessed the comparative efficacy and acceptability […]
Introduction: Li et al. (2021), in their meta-analysis published in Journal of Affective Disorders, assessed the comparative efficacy and acceptability […]
Introduction: In their 2018 article in Current Behavioral Neuroscience Reports, Gerhard and Duman provide a comprehensive analysis of rapid-acting antidepressants,
Introduction: The 2021 study by Aykac and Kalkan, published in Global Medical Genetics, explores epigenetic mechanisms underpinning PTSD. Using rat
Introduction: Dr. S. Kohtala’s 2021 review in Pharmacological Reports offers a comprehensive examination of ketamine’s 50-year history. Initially developed as
Introduction: Shi et al.’s 2024 meta-analysis, published in the Journal of the College of Physicians and Surgeons Pakistan, evaluates the
Introduction: Kawczak et al.’s 2024 review in Biomedicines explores ketamine, esketamine, and arketamine’s mechanisms of action and their applications in
Introduction In this clinically-focused systematic review, Sarris et al. (2020) examine the evidence for medicinal cannabis in psychiatric disorders, including
Introduction In a 2023 study published in Behavioral Pharmacology, Suárez Santiago and colleagues investigated the use of ketamine as a
Introduction In a 2022 commentary in the American Journal of Psychiatry, Dr. Ned H. Kalin highlights the pressing need to
Introduction Eating disorders such as anorexia nervosa and binge eating disorder are notoriously difficult to treat. In their 2022 publication